Ming‐Li Hsieh

Chang Gung Memorial Hospital

Papers

1

Total Citations

3

H-Index

1

About

Ming‑Li Hsieh investigates the complex interplay between adipose tissue and cancer, with a primary focus on prostate cancer. Her research challenges conventional assumptions about obesity and tumor progression by revealing that periprostatic adipose tissue can actually inhibit early‑stage prostate cancer through the secretion of apoptotic factors, a mechanism driven by the local immune response. This groundbreaking work, published in 2024, has already garnered 3 citations, signaling its immediate impact on the field. Hsieh’s contributions are particularly notable for reframing the role of visceral fat—long considered a risk factor—as a potential natural barrier during the initial phases of malignancy. By integrating immunology, oncology, and metabolic physiology, she provides a nuanced understanding of how body composition influences cancer biology. Her findings hold promise for developing novel therapeutic strategies that leverage the body’s own adipose‑immune interactions. For students and researchers, Hsieh’s work exemplifies how questioning established paradigms can lead to transformative insights in cancer research.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Chang Gung Memorial Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago